Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain

Summary

In a small, well-characterized sample of prescription opioid abusers (POAs) with chronic pain and on buprenorphine therapy, this study will investigate the utility and feasibility of two novel tracer compounds, and in combination with a standard marker (riboflavin), to monitor adherence to study drug prescription in the parent clinical trial.

Timeline

Start

2014-12

Primary completion

2016-01

Completion

2016-01

Drugs

Indications